ASX · ALC.AX
Alcidion Group Limited
A$0.11-A$0.01 (-4.35%)
Alcidion Group Limited’s quoted price sits in the lower half of its reported 52-week range, 24.14% below the high.
Loading market information…
ASX · SHG.AX · AUD
Stock price, earnings
Quote as of Oct 30, 2026, 03:20 AM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
Singular Health Group Ltd’s quoted price sits in the lower half of its reported 52-week range, 40.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Singular Health Group Ltd’s next earnings report is currently expected on Feb 19, 2027, with estimated earnings per share of -A$0.01. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Singular Health Group Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Singular Health Group Ltd operates as a medical technology enterprise dedicated to developing and commercializing a volumetric rendering platform (VRP). This advanced platform facilitates the three-dimensional and virtual reality presentation of anatomy, drawing upon standard radiological imaging. Among its key offerings are the 3Dicom Viewer, a cross-compatible software application designed for users to engage with conventional 2D medical images; 3DicomVSP, a complete system for surgical planning; Health Academy, a adaptable, multi-language platform delivering structured, curriculum-aligned educational modules; and GeoVR, a cloud-based solution specifically engineered for the mineral resources industry. The company, founded in 2017, is headquartered in Subiaco, Australia.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:43 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$0.11-A$0.01 (-4.35%)
Alcidion Group Limited’s quoted price sits in the lower half of its reported 52-week range, 24.14% below the high.
A$0.26+A$0.01 (+2.0%)
Mach7 Technologies Limited’s quoted price sits in the lower half of its reported 52-week range, 62.77% below the high.
A$0.44+A$0.05 (+12.99%)
Cyclopharm Limited’s quoted price sits in the lower half of its reported 52-week range, 66.28% below the high.
A$0.09-A$0.00 (-1.12%)
Amplia Therapeutics Limited’s quoted price sits in the lower half of its reported 52-week range, 68.0% below the high.
A$0.37+A$0.00 (0.0%)
Medical Developments International Limited’s quoted price sits in the lower half of its reported 52-week range, 48.61% below the high.
A$0.10-A$0.01 (-4.76%)
Doctor Care Anywhere Group PLC’s quoted price sits in the lower half of its reported 52-week range, 48.72% below the high.
A$0.04-A$0.00 (-5.13%)
Micro-X Limited’s quoted price sits in the lower half of its reported 52-week range, 67.83% below the high.
A$0.07A$0.00 (0.0%)
Beamtree Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 68.44% below the high.
